Research in idiopathic pulmonary fibrosis is progressing rapidly, with the goal of delivering more treatments to patients at ...
WHISTLE-PF will test the efficacy of various daily oral doses of ENV-101 against a placebo in adults with idiopathic ...
( MENAFN - Mid-East Info) Interstitial Lung disease Summit 2024 brings together more than 140 healthcare professionals from ...
The ILD Summit is accredited by the American Association of Continuing Medical Education (ACCME) and the British Academy of ...
Acute exacerbations are common and life-threatening in progressive pulmonary fibrosis. Learn about their impact on survival ...
The patient was diagnosed with silicosis based on clinical history, imaging features, and bronchoscopy with biopsy, which ...
Background Idiopathic pulmonary fibrosis (IPF) is a disease of progressive lung scarring. There is a known association ...
Congress 2024 spanned various topics, including artificial intelligence–powered robots transforming respiratory care and late ...
Jean C. Pfau, Ph.D. and Kinta Serve provide their perspective on asbestos, the pleural cavity, and autoimmune disease ...
The researchers hope their discoveries will lead to novel strategies to not just slow fibrosis but promote functional repair ...